Theravance Biopharma Overview
Theravance Biopharma Target Price
Analysts' 12-month price predictions for TBPH.
Share Price
$11.03
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-11-13 | Leerink PartnersDavid Risinger | $10 |  9.3% downside |  |
| 2024-08-06 | H.C. WainwrightDouglas Tsao | $15 |  36% upside | |
| 2024-04-12 | BTIGJulian Harrison | $21 | 90.4% upside | |
| 2022-11-17 | Leerink Partners | $14 | 26.9% upside | |